Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Bibliographic Details
Main Authors:	Eva Gijbels, Kevin De Muynck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Aude Vanlander, Frederik Berrevoet, Bart Hendrikx, Anne Hoorens, Hans Van Vlierberghe, Mathieu Vinken, Lindsey Devisscher
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-01-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S235230422200040X

Similar Items

Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model
by: Eva Gijbels, et al.
Published: (2020-10-01)

Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient
by: Eva Gijbels, et al.
Published: (2021-10-01)

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
by: Kevin De Muynck, et al.
Published: (2021-10-01)

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
by: Bart Vanderborght, et al.
Published: (2020-10-01)

Expression of connexins and pannexins in diseased human liver
by: Kaat Leroy, et al.
Published: (2022-08-01)

Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
by: Vânia Vilas-Boas, et al.
Published: (2020-03-01)

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
by: Astrid Vandierendonck, et al.
Published: (2021-01-01)

Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
by: Stef De Lombaerde, et al.
Published: (2017-01-01)

Cholestasis Differentially Affects Liver Connexins
by: Axelle Cooreman, et al.
Published: (2020-09-01)

The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis
by: Hanife Yurdakul Ertan, et al.
Published: (2023-01-01)

Early Initiation of a Standardized Open Abdomen Treatment With Vacuum Assisted Mesh-Mediated Fascial Traction Achieves Best Results
by: Frederik Berrevoet, et al.
Published: (2021-02-01)

Quality of life after open versus laparoscopic preperitoneal mesh repair for unilateral inguinal hernias
by: Simon Corthals, et al.
Published: (2021-10-01)

Gamma-Glutamyl Transferase: A Friend against Cholestatic Itch? A Retrospective Observational Data Analysis in Patients with Extrahepatic Cholestasis
by: Floris W. Haijer, et al.
Published: (2023-01-01)

Proteomics data in vitiligo: a scoping review
by: Danique Berrevoet, et al.
Published: (2024-04-01)

Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial
by: Jurgen van Limmen, et al.
Published: (2020-09-01)

Canonical and Non-Canonical Roles of Connexin43 in Cardioprotection
by: Olga M. Rusiecka, et al.
Published: (2020-08-01)

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
by: Guilherme Ribeiro Romualdo, et al.
Published: (2021-11-01)

Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
by: Luís Filipe Abreu de Carvalho, et al.
Published: (2023-09-01)

The Transition from Experimental Data to Clinical Practice Using P4HB Mesh in Ventral Hernia Repair
by: Frederik Berrevoet
Published: (2022-02-01)

Prevention of Incisional Hernias after Open Abdomen Treatment
by: Frederik Berrevoet
Published: (2018-02-01)

Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis
by: Khadija M. Alawi, et al.
Published: (2017-05-01)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
by: Eva Persyn, et al.
Published: (2022-09-01)

Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice
by: Roni F. Kunst, et al.
Published: (2024-01-01)

The genetics of complex cholestatic disorders.
by: Hirschfield, G, et al.
Published: (2013)

Current Therapies for Cholestatic Diseases
by: Nahum Méndez-Sánchez, et al.
Published: (2023-06-01)

Trifluoperazine-Induced Cholestatic Jaundice
by: Arezoo Saeedinia, et al.
Published: (2010-08-01)

Trifluoperazine-induced cholestatic jaundice.
by: Vandad Sharifi, et al.
Published: (2010-09-01)

Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in CholestasisSummary
by: Ludovica Ceci, et al.
Published: (2024-01-01)

Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody
by: Roos Van Den Noortgate, et al.
Published: (2023-01-01)

Cholestasis and Pregnancy
by: A. Daniilidis, et al.
Published: (2008-01-01)

The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023-10-01)

Ciprofloxacin-induced acute cholestatic hepatitis
by: Evangelos Cholongitas, et al.
Published: (2009-10-01)

Cholestatic pruritus: a knowledge update
by: Thaís Reginatto Nietsche, et al.
Published: (2022-06-01)

Cholestatic hepatitis due to Salmonella typhi
by: Ayse Albayrak, et al.
Published: (2011-04-01)

Pruritus in chronic cholestatic liver diseases
by: E. V. Vinnitskaya, et al.
Published: (2017-12-01)

Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease
by: Sanne Van Campenhout, et al.
Published: (2020-04-01)

The open anterior component separation technique for large ventral and incisional abdominal wall reconstruction
by: Frederik Berrevoet, et al.
Published: (2022-01-01)

Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers
by: Jimme K. Wiggers, et al.
Published: (2017-04-01)

Drug-induced cholestasis assay in primary hepatocytes
by: Pieter Van Brantegem, et al.
Published: (2020-01-01)

Prolonged Cholestatic Liver Disease Secondary to Methotrexate
by: Yahya Atayan, et al.
Published: (2015-12-01)